Who is sponsoring NCT00301353?

NCT00301353 is sponsored by TNO.

What condition does NCT00301353 study?

NCT00301353 studies Osteoporosis.

What drugs are being tested in NCT00301353?

Interventions: Isoflavones-enriched foods.

What is the status of NCT00301353?

NCT00301353 is currently COMPLETED.

Last reviewed 2015-05-20 · How we verify

Effects of Phytoestrogen-rich Diets on Bone Turnover in Postmenopausal Women

NCT00301353 NA COMPLETED

Osteoporosis is a major health problem. It was hypothesized that isoflavone-containing products may be a potential alternative to HRT for preventing bone loss during the menopausal transition. We investigated whether one-year consumption of isoflavone-enriched foods affected bone mineral density, bone metabolism and hormonal status in early postmenopausal women in a randomized double-blind, placebo controlled parallel multi-centre trial.

Details

Lead sponsor	TNO
Phase	NA
Status	COMPLETED
Enrolment	300
Start date	2002-10
Completion	2004-07

Conditions

Osteoporosis

Interventions

Isoflavones-enriched foods

Primary outcomes

Bone mineral density of total body and lumbar spine (DXA)

Countries

France, Italy, Netherlands